AR and prostate cancer: Furthermore, AR positive cell lines appear more sensitive to IKBKE inhibition upon comparison of GI50 values (Supplementary Figure S6E–G) and ‘normal’ prostate cancer cells appear to be less sensitive (Supplementary Figure S6H).